Brief: Indian Pharma Firms Sent Notices By Govt Body For Introducing Drugs Without Approval
July 23 (Reuters) -
* INDIAN COS INTRODUCING 22 DRUGS WITHOUT PRIOR APPROVAL OF
THE
NATIONAL PHARMACEUTICAL PRICING AUTHORITY HAVE BEEN ISSUED
NOTICES - GOVERNMENT STATEMENT
* NPPA HAS SO FAR ISSUED DEMAND NOTICES FOR AN AMOUNT OF
1.01
BILLION RUPEES AGAINST DEFAULTING COMPANIES - GOVERNMENT
STATEMENT
* INDIAN COMPANIES ISSUED NOTICES BY NPPA INCLUDE ALEMBIC
PHARMA,
BIOCON LTD, CIPLA, LUPIN, WOCKHARDT, SANOFI INDIA, DR REDDYS
LABS - GOVERNMENT
Source text for Eikon: (http://bit.ly/2yfGeIB)
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Sanofi India
See all newsSanofi India gains as quarterly profit doubles on strong diabetes business performance
Brief: Sanofi India Sept-Quarter Profit 1.17 Billion Rupees
Brief: Sanofi India Gets Tax Notice Worth 164 Million Rupees
Brief: Sanofi India Says Supreme Court Of India Has Dismissed Co's Petition Seeking Quashing Of Criminal Proceedings
Brief: Sanofi India Says Tax Demand Of 7.3 Million Rupees Vacated For AY 2019-20